Robert F. Kennedy Jr. remains entrenched as HHS Secretary after his narrow 52-48 Senate confirmation in February 2025 and subsequent swearing-in, with trader consensus at 68.5% on "No" reflecting his stability through ongoing congressional testimonies, including April 2026 hearings on the FY2026 budget request where he defended Make America Healthy Again priorities amid Democratic calls for resignation. Recent subordinate departures—the FDA commissioner amid internal pressures and chief spokesperson over e-cigarette policy on May 13—have not signaled his ouster, nor have reports of White House sidelining or hantavirus response defenses with President Trump. Absent major scandals or midterm shifts, historical cabinet retention patterns support expectations he serves past December 31, 2026.
Eksperimental na AI-generated summary na nire-reference ang Polymarket data. Hindi ito trading advice at wala itong papel sa kung paano nire-resolve ang market na ito. · Na-update$18,792 Vol.
$18,792 Vol.
$18,792 Vol.
$18,792 Vol.
An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Binuksan ang Market: Mar 19, 2026, 2:02 PM ET
Resolver
0x65070BE91...An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Resolver
0x65070BE91...Robert F. Kennedy Jr. remains entrenched as HHS Secretary after his narrow 52-48 Senate confirmation in February 2025 and subsequent swearing-in, with trader consensus at 68.5% on "No" reflecting his stability through ongoing congressional testimonies, including April 2026 hearings on the FY2026 budget request where he defended Make America Healthy Again priorities amid Democratic calls for resignation. Recent subordinate departures—the FDA commissioner amid internal pressures and chief spokesperson over e-cigarette policy on May 13—have not signaled his ouster, nor have reports of White House sidelining or hantavirus response defenses with President Trump. Absent major scandals or midterm shifts, historical cabinet retention patterns support expectations he serves past December 31, 2026.
Eksperimental na AI-generated summary na nire-reference ang Polymarket data. Hindi ito trading advice at wala itong papel sa kung paano nire-resolve ang market na ito. · Na-update
Mag-ingat sa mga external link.
Mag-ingat sa mga external link.
Mga Madalas na Tanong